A New Way In: How Outside-the-box Science Sparked a Revolution in Targeting KRAS
At the recent AACR Conference on Pancreatic Cancer, Kevan M. Shokat, PhD, FAACR, received the 2026 Stephenson Global Prize...
Tag: KRAS inhibitors
At the recent AACR Conference on Pancreatic Cancer, Kevan M. Shokat, PhD, FAACR, received the 2026 Stephenson Global Prize...
We highlight some of the many innovations showcased at the inaugural AACR Drug Discovery and Development (AACR D3) conference,...
The AACR D3 edition of “From the Bench” highlights cutting-edge approaches from the meeting that could shape the next...
Researchers at the AACR Annual Meeting 2024 shared how AACR Project GENIE data is helping their studies.
Once considered undruggable, mutant KRAS has emerged in recent years as a viable target for anticancer therapeutics. As a...